Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 6 October 2025, 14:00 HKT/SGT
Share:
    

Source: Olympus
Olympus Launches SecureFlex, a Single-use Fine Needle Biopsy Device

TOKYO & HAMBURG, Oct 6, 2025 - (JCN Newswire) - Olympus Corporation (Olympus), a global MedTech company committed to making people’s lives healthier, safer and more fulfilling, today announced the launch of SecureFlex, a single-use fine needle biopsy device. SecureFlex will be commercially available in Europe and Japan in Autumn 2025, with a subsequent global rollout subject to regulatory requirements such as product registration and market clearance.

Designed for use with an ultrasound endoscope, SecureFlex supports endoscopic ultrasound-guided fine needle biopsy (EUS-FNB) of submucosal and extramural lesions within the gastrointestinal tract. Its primary clinical application is in the diagnosis of diseases such as pancreatic cancer.

EUS-FNB: Endoscopic Ultrasound-guided Fine Needle Biopsy

EUS-FNB is an examination technique that combines ultrasound and endoscopy technologies, enabling physicians to obtain tissue or cell biopsies of lesions from areas such as the pancreas that cannot be accessed directly by the endoscope. For example, a needle biopsy may be performed through the wall of the gastrointestinal tract with the ultrasound scope being inserted orally and ultrasound imaging used for sub-mucosal visualization. Collected tissue samples are then sent for pathological evaluation to determine whether the lesion is benign or malignant.

NA-U210H
NA-U210H

In recent years, advances in the treatment of pancreatic cancer—including molecularly targeted therapies and immunotherapies—have increased the need for high-quality tissue sampling. For these therapies, it is often critical to obtain larger and higher-quality samples to ensure accurate treatment decisions.

The newly launched SecureFlex has been developed to address these needs, incorporating feedback from physicians. SecureFlex contributes to more precise treatment planning for pancreatic cancer and other gastrointestinal diseases.

Dual-Beveled Raptor Tip Supports the Collection of Larger Specimens1

Dual-Beveled Raptor Tip, with its multi-dimensional cutting surfaces, enables the collection of larger, intact tissue samples while preserving cellular architecture through precise tissue execution1 for procedural efficiency. The outer distal cutting surface forms fine edge to support smooth tissue puncture and the inner proximal cutting surface minimizes tissue escape1.

Dual-Beveled Raptor Tip
Dual-Beveled Raptor Tip

Consistent Access to Complex Anatomical Structures

EUS-FNB procedures often require the needle to be inserted into difficult-to-access locations, such as pancreatic head and uncinate process. SecureFlex’s nitinol construction and a multi-layer sheath design2 support effective access to complex anatomical structures without frequent scope adjustments.

1 Compared to our conventional needle
2 Nitinol construction refers to 19G and 22G sizes

About Olympus

At Olympus, we are committed to Our Purpose of making people’s lives healthier, safer and more fulfilling. As a global medical technology company, we partner with healthcare professionals to provide innovative solutions and services for early detection, diagnosis and minimally invasive treatment, aiming to improve patient outcomes by elevating the standard of care in targeted disease states. For more than 100 years, Olympus has pursued a goal of contributing to society by producing products designed with the purpose of delivering optimal outcomes for its customers around the world. For more information, visit https://www.olympus-global.com/ and follow our global LinkedIn and X accounts.

Media contact:
Mail: Global-Public_Relations@olympus.com 

Olympus Corp [TYO: 7733] [ADR: OLYMY] [STU: OLY1] [FRA: OLYS] https://www.olympus-global.com  




Topic: Press release summary
Source: Olympus

Sectors: Healthcare & Pharm, MedTech
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Olympus
Sept 30, 2025 21:00 HKT/SGT
Olympus Launches OLYSENSE CAD/AI in the US and Europe
Sept 30, 2025 12:00 HKT/SGT
Olympus Commits to Advancing Sustainable Packaging Enabled by DuPont(TM) Tyvek(R) with Renewable Attribution
July 25, 2025 15:00 HKT/SGT
Olympus Enters Strategic Partnership to Develop Endoluminal Gastrointestinal Robotics
Apr 25, 2025 14:30 HKT/SGT
Olympus Appoints New CEO
Apr 22, 2025 12:00 HKT/SGT
A Decade of Olympus India's Commitment to Community Welfare
Feb 26, 2025 10:00 HKT/SGT
Olympus Announces Milestone for iTind(TM) Device with Expanded Availability Across Major APAC Markets
Feb 10, 2025 10:00 HKT/SGT
Olympus Recognized on CDP's "A List", the Highest Rating in the Field of Climate Change
Dec 24, 2024 10:00 HKT/SGT
Olympus Named to Dow Jones Sustainability World Index for the Fourth Consecutive Year
Nov 19, 2024 14:30 HKT/SGT
NTT and Olympus Joint Demonstration Shows IOWN APN's Low-latency Capability Can Be Used for Real-time Diagnosis and Treatment on a Remote Server to Realize World's First Cloud Endoscopy System
Sept 30, 2024 14:00 HKT/SGT
Olympus Launches VISERA S, a New Imaging Platform
More news >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: